Multilevel Intervention for Precision Oncology
Part of paid clinical trials in New York, New York.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06825715
- Status
- Recruiting
Conditions
- Advanced Cancers of the Prostate
- Cancers of the Lung
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Multilevel intervention — OTHER3 components: patient education video, provider audit/feedback, and EMR ordering change
Study Details
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Key Dates
- Start date
- Jul 2, 2025
- Status verified
- Jul 2025
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2030
Study Design
- Enrollment
- 2,653 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: During intervention periodAll sites will receive the 3 level intervention of patient education, provider audit/feedback, and EMR order change.
Primary Outcome Measure
Use of molecular testing [ Time Frame: 3 years ]
Central Contacts
- Antoinette Vo, BA MA(212) 686-7500
- Daniel J Becker, MD(212) 686-7500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA NY Harbor Healthcare System, New York, NY | New York | New York | 10010-5011 | Daniel J Becker, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site